MARKET

LFCR

LFCR

Lifecore Biomedical Inc
NASDAQ
7.07
+0.13
+1.87%
Closed 16:00 12/19 EST
OPEN
7.01
PREV CLOSE
6.94
HIGH
7.19
LOW
6.87
VOLUME
206.26K
TURNOVER
0
52 WEEK HIGH
8.90
52 WEEK LOW
3.679
MARKET CAP
260.37M
P/E (TTM)
118.82
1D
5D
1M
3M
1Y
5Y
1D
Lifecore Biomedical Selected by Nirsum Laboratories to Provide CDMO Services for NRS-033 Clinical Development
Barchart · 1d ago
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Barchart · 1d ago
Lifecore selected by Nirsum Laboratories to provide CDMO services
TipRanks · 1d ago
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
Barchart · 1d ago
Weekly Report: what happened at LFCR last week (1209-1213)?
Weekly Report · 4d ago
Weekly Report: what happened at LFCR last week (1202-1206)?
Weekly Report · 12/09 09:18
Lifecore management to meet virtually with Craig-Hallum
TipRanks · 12/02 21:20
Weekly Report: what happened at LFCR last week (1125-1129)?
Weekly Report · 12/02 09:18
More
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Webull offers Lifecore Biomedical Inc stock information, including NASDAQ: LFCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LFCR stock methods without spending real money on the virtual paper trading platform.